// App-Quantinova.ai

395 : Molecular Subgroups of T Cell Acute Lymphoblastic Leukemia in Adults Treated According to GMALL Protocols

Researchers

Presenter

  • Martin Neumann

Principal Investigators

  • Sonja Hnzelmann

  • Alina Hartmann

  • Heiko Trautmann

  • Jutta Ortiz Tanchez

  • Cornelia Schlee

  • Michael P Schroeder

  • Lars R. Fransecky

  • Sebastian Vosberg

  • Walter Fiedler

  • Nael Alakel

  • Mustafa Kondakci

  • Michael Starck

  • Stefan Schwartz

  • Carsten Mller-Tidow

  • Folker Schneller

  • Albert Reichle

  • Thomas Burmeister

  • Philipp A. Greif

  • Monika Brggemann

  • Nicola Goekbuget

  • Claudia D Baldus

Medical Centers

  • Medical Department II of Hematology and Oncology, University Hospitals of Schleswig Holstein, Campus Kiel, Germany.

  • Hematology and Oncology,University Hospital Schleswig-Holstein,Kiel,Germany

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • Department of Neurosurgery, Ludwig-Maximilians University Munich, Munich, Germany

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Essen University Hospital, Essen, Germany

  • Department of Hematology, Oncology and Clinical Immunology, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany,

  • Medical Department I, Hospital München-Schwabing, München, Germany

  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

  • Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

  • Department of Hematology/Oncology, University Hospital Regensburg, Regensburg, Germany

  • University Hospital, Department of Medicine II, Hematology/Oncology, Head of Study Center Depart of Medicine II, Hematology/Oncology Goethe University Hospital, Frankfurt, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A